EUVIMEDEUVIMED entdecken
Open Access

Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation

Wei Xiang iD, Hongwei Lv iD, Fuxue Xing iD, Xiaoyan Sun, Yue Ma, Lu Wu iD, Guishuai Lv, Qianni Zong, Liang Wang, Zixin Wu, Qiyu Feng, Wen Yang iD und 1 weitere

Science Advances · 08.12.2023 · 9 (49)

DOI: 10.1126/sciadv.adi2465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 08.12.2023. Verfasst von Wei Xiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hef…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Neoplasms. Die Arbeit wurde bisher 163-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine 5′-triphosphate citrate lyase (ACLY) is a cytosolic enzyme that converts citrate into acetyl–coenzyme A for fatty acid and cholesterol biosynthesis. ACLY is up-regulated or activated in many cancers, and targeting ACLY by inhibitors holds promise as potential cancer therapy. However, the role of ACLY in cancer immunity regulation remains poorly understood. Here, we show that ACLY inhibition up-regulates PD-L1 immune checkpoint expression in cancer cells and induces T cell dysfunction to drive immunosuppression and compromise its antitumor effect in immunocompetent mice. Mechanistically, ACLY inhibition causes polyunsaturated fatty acid (PUFA) peroxidation and mitochondrial damage, which triggers mitochondrial DNA leakage to activate the cGAS-STING innate immune pathway. Pharmacological and genetic inhibition of ACLY overcomes cancer resistance to anti–PD-L1 therapy in a cGAS-dependent manner. Furthermore, dietary PUFA supplementation mirrors the enhanced efficacy of PD-L1 blockade by ACLY inhibition. These findings reveal an immunomodulatory role of ACLY and provide combinatorial strategies to overcome immunotherapy resistance in tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenNeoplasmsMiceAnimalsFatty Acids, UnsaturatedNucleotidyltransferasesImmunotherapy

Substanzen

B7-H1 AntigenFatty Acids, UnsaturatedNucleotidyltransferases

Autor:innen und Institutionen

  • Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230027, China.
  • International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute/Hospital, Naval Medical University (Second Military Medical University), Shanghai 200438, China.
  • National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Shanghai 201805, China.
  • First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, China.
  • Fourth Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), Shanghai 200438, China.
  • Shanghai Key Laboratory of Hepatobiliary Tumor Biology, Shanghai 200438, China.

ORCID-Profile: Wei Xiang, Hongwei Lv, Fuxue Xing, Lu Wu, Wen Yang, Hongyang Wang

Zitieren

APA

Xiang, W., Lv, H., Xing, F., Sun, X., Ma, Y., Wu, L., Lv, G., Zong, Q., Wang, L., Wu, Z., Feng, Q., Yang, W., & Wang, H. (2023). Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Science Advances, 9(49). https://doi.org/10.1126/sciadv.adi2465

Vancouver

Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, et al. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Science Advances. 2023;9(49). doi:10.1126/sciadv.adi2465

BibTeX
@article{Xiang2023,
  author = {Xiang, Wei and Lv, Hongwei and Xing, Fuxue and Sun, Xiaoyan and Ma, Yue and Wu, Lu and Lv, Guishuai and Zong, Qianni and Wang, Liang and Wu, Zixin and Feng, Qiyu and Yang, Wen and Wang, Hongyang},
  title = {Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {49},
  doi = {10.1126/sciadv.adi2465}
}
Kostenlos starten →